Minor Cannabinoids and Drug Tests: What Actually Shows Up
What standard drug screens actually detect, how CBD, CBG, CBN, CBC and THC variants behave, and how to buy products with lower testing risk.
What are Minor Cannabinoids?
Minor cannabinoids are a group of compounds found in hemp, alongside the more well-known THC and CBD. These compounds include, but are not limited to, cannabigerol (CBG), cannabichromene (CBC), cannabidiolic acid (CBDA), and cannabinol (CBN). Each minor cannabinoid has unique properties and potential benefits.Properties of Minor Cannabinoids
- CBG: Often referred to as the 'stem cell' of cannabinoids, CBG is believed to have anti-inflammatory, antibacterial, and neuroprotective properties.
- CBC: CBC is known for its potential anti-inflammatory and analgesic effects.
- CBDA: CBDA is a precursor to CBD and is thought to have anti-inflammatory and antibacterial properties.
- CBN: CBN is a byproduct of THC and is often used for its potential sedative effects.
Benefits of Minor Cannabinoids
- Inflammation Reduction: Many minor cannabinoids have been found to have anti-inflammatory properties, which can be beneficial for those with chronic pain or inflammatory conditions.
- Neuroprotective Effects: CBG, in particular, has been studied for its neuroprotective properties, which may be helpful for those with neurological disorders.
- Antibacterial Properties: CBC and CBDA have shown promise in inhibiting the growth of bacteria, which could be beneficial for those with gastrointestinal issues or infections.